期刊文献+

口服Ⅱ型胶原肽-霍乱毒素B亚单位复合物对胶原诱导性关节炎的影响 被引量:1

Effect of oral administration of type Ⅱ collagen peptide-cholera toxin B subunit complex on collageninduced arthritis
原文传递
导出
摘要 目的关节炎急性期胶原诱导性关节炎(CIA)小鼠口服Ⅱ型胶原免疫活性肽段(250—270))[CⅡ(250—270)]和霍乱毒素B亚单位(CTB)的共价复合物,观察其是否能产生免疫耐受。方法DBA/1小鼠分成I、Ⅱ、Ⅲ、Ⅳ组,I组为健康对照,Ⅱ、Ⅲ、Ⅳ组小鼠制成CIA。Ⅲ组小鼠于关节炎发病率达到100%后,灌胃CⅡ(250—270)-CTB共价复合物,Ⅳ组小鼠于初次免疫后第14日灌胃CII(250-270)与CTB的混合物。记录小鼠关节炎症评分及病理评分。关节炎发生率比较采用Fisher精确概率法,关节炎累计评分及组织病理累计评分采用方差分析。结果I、Ⅱ、Ⅲ、Ⅳ组的关节炎发生率分别为0、100%、100%和25%;关节炎累计评分均值分别为0、5.0±1.7、10.8±2.8和1.0±2.0;关节炎病理累计评分均值分别为0、16±8、32±13和7±6。结论CIA小鼠于免疫后的关节炎临床前期口服CⅡ(250-270)与CTB的混合物能抑制关节炎的发生及严重程度,关节炎急性炎症期口服CⅡ(250—270)-CTB共价复合物后可能使关节炎症加重。 Objective The aim of this study is to investigate whether oral administration of collagen Ⅱ peptide (250-270) [C Ⅱ(250-270)] -cholera toxin B subunit (CTB) complex could effectively set up oral immune tolerance to collagen-induced arthritis (CIA) in mice. Methods DBA/1 mice were divided into Ⅰ , Ⅱ , Ⅲ and ivgroups. GroupⅠ was normal control group. Collagen type Ⅱ emulsified in Freund's complete adjuvant were injected to mice of groups Ⅱ , Ⅲ and Ⅳ twice from the base of the tail. Mice of group Ⅲ were fed with C Ⅱ (250-270)-CTB covalent complex twice after the arthritis was developed. Mice of group Ⅳ were fed with C Ⅱ (250-270) and CTB mix at the 14th day after primary immunization. Visual scores and histopathologic scores of arthritis were recorded. The frequencies of arthritis between the groups were compared using Fisher's exact test. The clinical and histological severity of arthritis were analyzed by ANOVA. Results The frequencies of arthritis in groups I , Ⅱ, Ⅲand Ⅳ were 0, 100%, 100% and 25% respectively. Average accumulative scores of arthritis were 0, 5.0±1.7, 10.8±2.8 and 1.0±2.0 respectively. Average accum-ulative histopathological scores of arthritis were 0, 16±8, 32±13 and 7±6 respectively. Conclusion Oral administration of C II (250-270) and CTB mix in arthritis mice after C Ⅱ immunization can suppress the onset and severity of arthritis. Oral administration of C Ⅱ (250-270)-CTB covalent complex in the acute stage of arthritis can accelerate arthritis.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2011年第9期634-637,I0005,共5页 Chinese Journal of Rheumatology
基金 基金项目:辽宁省教育厅高等学校科研项目计划(2008808)
关键词 关节炎 实验性 免疫耐受 胶原Ⅱ型 霍乱毒素 小鼠 Arthritis, experimental Immune tolerance Collagen type Ⅱ Cholera toxin Mice
  • 相关文献

参考文献10

  • 1Rosloniec EF, Cremer M, Kang AH, et al. Collagen-induced arthritis. Curr Protoc Immunol, 2010, 89: 1551-15525. 被引量:1
  • 2Zhu P, Li XY, Wang HK, et al. Oral administration of type-Ⅱ collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis. Clin Immunol, 2007, 122: 75-84. 被引量:1
  • 3Sun JB, Czerkinsky C, Holmgren J. Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B suhunit. Scand J Immunol, 2010, 71 : 1-11. 被引量:1
  • 4Tarkowski A, Sun JB, Holmdahl R, et al. Treatment of experimental autoimmune arthritis by nasal administration of a type Ⅱ collagen-cholera toxoid conjugate vaccine. Arthritis Rheum, 1999, 42: 1628-1634,. 被引量:1
  • 5Sims NA, Green JR, Glatt M, et al. Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis. Arthritis Rheum, 2004, 50: 2338-2346. 被引量:1
  • 6Terato K, Ye XJ, Miyahara H, et al. Induction of chronic au- toimmune arthritis in DBA/1 mice by oral administration of type Ⅱ collagen and Escherichia coli lipopolysaccharide. Br J Rheumatol, 1996, 35: 828-838. 被引量:1
  • 7Burkart V, Kim Y, Kauer M, et al. Induction of tolerance in macrophages by cholera toxin B chain. Pathobiology, 1999, 67: 314-317. 被引量:1
  • 8Langridge W, Denes B, Fodor I. Cholera toxin B subunit modulation of mucosal vaccines for infectious and autoimmune diseases. Curr Opin Investig Drugs, 2010, 11: 919-928. 被引量:1
  • 9Sun JB, Rask'C, Olsson T, et al. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc Natl Acad Sci USA, 1996, 9: 7196-7201. 被引量:1
  • 10Stanford M, Whittall T, Bergmeier LA, et al. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease. Clin Exp Immunol, 2004, 137: 201-208. 被引量:1

同被引文献9

  • 1Thompson HS, Staines NA. Suppression of collagen-induced ar-thritis with pergastrically or intravenously administered type II col- lagen. Agents Actions, 1986, 19(5-6) : 318-319. 被引量:1
  • 2Zhu P, Li XY, Wang HK, et al. Oral administration of type Ⅱ collagen peptide 250-270 suppresses specific ceUular and humoral immune response in collagen-induced arthritis. Clin Immunol, 2007, 122( 1 ) : 75-84. 被引量:1
  • 3Sun JB, Czerkinsky C, Holmgren J. Mucosally induced immuno- logical tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit. Scand J Immunol, 2010, 71 (1) : 1-11. 被引量:1
  • 4Tarkowski A, Sun JB, Holmdahl R, et al. Treatment of experi- mental autoimmune arthritis by nasal administration of a type II collagen-cholera toxoid conjugate vaccine. Arthritis Rheum, 1999, 42(8) : 1628-1634. 被引量:1
  • 5Cho YG, Cho ML, Min SY, et al. Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis. Autoimmun Rev, 2007, 7 ( 1 ) : 65-70. 被引量:1
  • 6Capini C, Jaturanpinyo M, Chang HI, et al. Antigen-specific sup- pression of inflammatory arthritis using liposomes. J Immunol, 2009, 182(6) : 3556-3565. 被引量:1
  • 7Tran MA, Watts RJ, Robertson GP. Use of liposomes as drug de- livery vehicles for treatment of melanoma. Pigment Cell Melanoma Res, 2009, 22(4) : 388-399. 被引量:1
  • 8Minaguchi J, Oohashi T, Inagawa K, et al. Transvascular accu- mulation of Sialyl Lewis X conjugated liposome in inflamed joints of collagen antibody-induced arthritic (CAIA) mice. Arch Histol Cytol, 2008, 71(3): 195-203. 被引量:1
  • 9谭刘欣,奚永志.Ⅱ型胶原免疫活性肽研究的进展[J].中华风湿病学杂志,2009,13(5):341-343. 被引量:6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部